NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Nuwellis, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.56+0.01 (+1.68%)

Close on Oct 19, 2026

Market cap: $101.13K
P/E (TTM): –
Dividend yield: –

Dividends

Nuwellis has not reported a dividend

No dividend per share appears in Nuwellis's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Nuwellis's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-35 reverse split on Aug 13, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NUWE.

Revenue growth8.4% · median 42.8%

Gross margin69.7% · median 55.6%

Operating margin-142.9% · median -83.4%

Net margin-125.6% · median -78.6%

Company	Revenue	Growth
OM	$117.80M	-1.3%
ELMD	$73.78M	+15.3%
HYPR	$16.54M	+53.2%
NMTC	$9.47M	+42.8%
NUWE	$9.01M	+8.4%
NRXS	$5.32M	+65.2%

Company

Next earnings (est.): Nov 11, 2026, before open
Exchange: Nasdaq
Industry: Electromedical & Electrotherapeutic Apparatus
Fiscal year ends: December 31
Employees: 24
Held by institutions: 0.6%
Auditor: Baker Tilly US, LLP
SEC CIK: 1506492

Advertisement
300 × 250